NGI during Covid-19 outbreak

NGI is still up and running during the Covid-19 pandemic, but we are experiencing some limitations in terms of personnel and key reagents. Each NGI node is following its respective host university recommendations and will continue operation until further notice.

Read more

Pacific Biosciences

Pacific Biosciences Single Molecule, Real-Time (SMRT) Sequencing technology provides the most comprehensive view of genomes, transcriptomes, and epigenomes.

Image: Courtesy of Pacific Biosciences of California, Inc.

SMRT sequencing technology generates reads tens of kilobases in length allowing to assemble complete genomes and sequence full-length transcripts. Technology is free of systematic errors and achieves >99.999% consensus accuracy. No bias based on GC content means sequencing through regions inaccessible to other technologies. Capturing sequence data from native DNA or RNA molecules enables highly accurate long reads with >99% single-molecule accuracy. With no PCR amplification step, base modifications are directly detected during sequencing.

To learn more about technology, visit Pacific Biosciences site.

Technologies within this category

PacBio Sequel II
The award-winning PacBio Sequel II System provides high throughput, cost effective, highly accurate long-read sequencing
PacBio Sequel
The Scalable Platform for SMRT Sequencing
Method Status

Service

We are routinely running this method. Please visit the Order Portal to place an order.

Keywords